Division of Novartis AG
Latest From Sandoz Inc.
Although Samsung has not provided 180-day advance notice of commercialization for Eticovo, its recently approved biosimilar to Enbrel, Amgen seeks a preliminary injunction because it has reason to believe the company is prepared to launch ‘imminently.’
Q1 Earnings Preview: While investors will look for updates on Aimovig and Evenity launches and a recently revealed legal battle with partner Novartis, Amgen's current blockbusters also are in the hotseat.
- Generic Drugs
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Novartis AG
- Senior Management
Greg Nulty, VP, Head, Finance & CFO
Patrick Genestin, VP, Bus. Dev. & Licensing
Carlos Sattler, MD, VP, Clin. Dev. & Medical Affairs
Scott Smith, VP, Commercial Operations, US
Anthony Maffia, III, VP, Regulatory Affairs
Carol Lynch, Pres.
- Contact Info
Phone: (609) 627-8500
100 College Rd. West
Princeton, NJ 08540
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.